[PLX] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
06-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -32.39%
YoY- -477.02%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 19,495 17,759 27,018 2,469 2,081 -11,195 1,384 55.34%
PBT 397 291 9,781 -15,141 -2,624 -12,419 -8,469 -
Tax -212 180 99 916 -189 -85,260 57 -
NP 397 291 9,781 -15,141 -2,624 72,900 -8,469 -
Tax Rate 53.40% -61.86% -1.01% - - - - -
Total Cost 19,098 17,468 17,237 17,610 4,705 -84,095 9,853 11.65%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 2.04 1.64 36.20 -613.24 -126.09 -651.18 -611.92 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 0.01 0.02 0.66 -1.08 -0.21 7.31 -0.91 -
EPS Diluted 0.01 0.02 0.66 -1.04 -0.21 7.31 -0.91 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.